Article Listing - 1997, An "Annus Horribilis" for Celltech

CORTICOSTEROIDS AND OPTIC NEURITIS

9 March 1992

Optic neuritis, an acute demyelinating disease of the optic nerve which often occurs in multiple sclerosis patients, can be successfully...

ROCHE CENTER ESTABLISHED IN USA

9 March 1992

A new study center for nervous system injuries at Washington University in St Louis, Missouri, is being set up to...

CHANGING FACE OF THE ASTHMA MARKET

9 March 1992

While some analysts have voiced belief that Glaxo may have a tough time getting its long-acting bronchodilator Serevent (salmeterol xinafoate)...

ROCHE TO PROMOTE GENENTECH'S DNase

9 March 1992

Swiss major Hoffmann-La Roche and Californian biotechnology concern Genentech last week announced four different international R&D agreements using their combined...

US GAO SLAMS FDA REVIEW OF OTCs

9 March 1992

There is less US Food and Drug Administration scrutiny of over-the-counter drug products than of prescription products, says a new...

ORPHAN DRUG BILL FACES VETO

9 March 1992

Sponsors of legislation now in the Senate which would reduce the market monopoly enjoyed by orphan drug makers fear that...

PRODUCT UPDATE FROM INTERNEURON PHARMA

9 March 1992

Massachusetts company Interneuron Pharma has signed an agreement with Purdue University to license exclusive worldwide rights to its putative antiparkinsonism...

HUMAN CARCINOMA ANTIGEN

9 March 1992

Massachusetts-based company Epigen Inc has signed an agreement with investigators at the University of Oslo, Norway, to characterize the HC...

NONABSORBABLE ANTIBIOTICS

9 March 1992

Decontamination of the digestive tract with topical nonabsorbable antibiotics does not improve survival among patients receiving mechanical ventilation in the...

BIOCHEM PHARMA'S JOHN GILLARD

9 March 1992

John Gillard has been appointed as director of therapeutic research at BioChem Pharma Inc of Canada. 1614869 COST CONTAINMENT MEASURES...

Showing 94761-94770 of 95368 articles